Back to search

National and Kapodistrian University of Athens

Μοριακή διάγνωση της μικρομεταστατικής νόσου στον καρκίνο μαστού

Abstract

dc:description

Circulating tumor cells represent an important biological link in the prevalence of breast cancer, between primary tumor and metastatic disease. CTCs have already been established as strong predictors of prognosis in patients with metastatic breast cancer. The expression of epithelial cancer marker CK-19 in 179 samples of patients with early breast cancer and we found out that the patients that were positive for mRNA of CK-19 were associates with disease free interval (P=0,0140) and overall survival (P=0,0510). Quantitative real-time PCR was developed for the transcription factor TWIST-1 and the gene HER-2. CTCs were detected concerning the expression of TWIST-1 in 12,5% of patients with early breast cancer, in 5.5% concerning the expression of HER-2 and in 11,1% in patients with verified metastasis. Quantitative multiplex real-time PCR was developed for the genes CK-19, MAGE A3, HER-2, PBGD. CTC’s were detected in patients with early breast cancer 42,2% for CK-19, 18,8% for MAGE A3, 12,5% for HER-2 and in patients with verified metastasis, 51,8% for CK-19, 14,8% for MAGE A3, 18,5% for HER-2.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Στρατή, Αρετή
  • Strati, Areti

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/26247

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Στρατή, Αρετή; Strati, Areti. Μοριακή διάγνωση της μικρομεταστατικής νόσου στον καρκίνο μαστού. National and Kapodistrian University of Athens, 2009. http://hdl.handle.net/10442/hedi/26247